The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
Launched by OTTAWA HEART INSTITUTE RESEARCH CORPORATION · Feb 21, 2018
Trial Information
Current as of July 06, 2025
Recruiting
Keywords
ClinConnect Summary
The MIST Trial is studying two methods of heart surgery for patients with coronary artery disease, a condition where blood vessels in the heart become blocked. One method is called Minimally Invasive Coronary Surgery (MICS CABG), which uses a small cut in the chest to perform the surgery. The other is conventional sternotomy CABG, which involves a larger incision down the middle of the chest. The goal of the trial is to see which method helps patients recover faster and improves their quality of life after surgery.
To participate in this trial, you need to be at least 18 years old and have significant blockages in your coronary arteries that require surgery. If you are chosen, you will complete quality of life questionnaires at different points after your surgery to help researchers understand how you are feeling and recovering. It's important to know that this study is currently recruiting participants, and your involvement could contribute to better treatment options for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older
- • Angiographically-confirmed multi-vessel coronary artery disease lesions with \>=70% in at least 2 major epicardial vessels in 2 or more coronary artery territories (left anterior descending (LAD), circumflex (CX) and right coronary artery (RCA)) OR lesions \>=50% in the left main (LM)
- • Patients who, in the opinion of the investigator, are amenable for coronary surgery through either median sternotomy or minimally-invasive approach.
- • Patients who are willing and able to comply with all follow-up study visits.
- Exclusion Criteria:
- • \<18 years of age
- • concomitant cardiac procedure with CABG (e.g. valve repair or replacement)
- • Previous cardiac surgery, mediastinal irradiation, or significant trauma to the chest
- • Contra-indications for MICS CABG, including: severe pectus excavatum; severe pulmonary disease; hemodynamically significant left subclavian stenosis; morbid obesity; severe left ventricular (LV) dysfunction; no adequate PDA or marginal branch target; absence of femoral pulse bilaterally.
- • Contraindications for conventional CABG via sternotomy
- • Concomitant life-threatening disease likely to limit life expectancy to \<2 years
- • Emergency CABG with hemodynamic compromise
- • Inability to provide informed consent.
About Ottawa Heart Institute Research Corporation
The Ottawa Heart Institute Research Corporation is a leading clinical research organization dedicated to advancing cardiovascular medicine through innovative research and clinical trials. Affiliated with the renowned University of Ottawa Heart Institute, the corporation focuses on conducting high-quality, ethically-driven studies that aim to improve patient outcomes and enhance understanding of heart-related diseases. With a commitment to collaboration and excellence, the organization engages multidisciplinary teams of researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective therapies and interventions for cardiovascular health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
La Crosse, Wisconsin, United States
Pittsburgh, Pennsylvania, United States
Ottawa, Ontario, Canada
Leuven, , Belgium
Toronto, Ontario, Canada
Taipei, , Taiwan
Houston, Texas, United States
Leipzig, Saxony, Germany
New Delhi, Delhi, India
Stuttgart, , Germany
Fresno, California, United States
Charlotte, North Carolina, United States
London, Ontario, Canada
Wuhan, Hubei Sheng, China
Jilin, Jilin, China
Bangalore, Karnataka, India
Ichinomiya, Aichi, Japan
New Delhi, Delhi, India
Urayasu, Chiba, Japan
Singapore, , Singapore
Patients applied
Trial Officials
Marc Ruel, MD
Principal Investigator
Ottawa Heart Institute Research Corporation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials